3E00XMZ
3E00XMZ: Introduction of Pigment into Skin and Mucous Membranes, External Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce of Pigment into Skin/Mucous Mem, Extern Approach
How 3E00XMZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration: What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective: the verb of the procedure
- 0Body partThe specific site
- XApproachHow the site was reached
- MDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E00XMZ
In CMS’s own ordering, which groups codes that differ by only the last character or two, usually the approach, device or qualifier.
- 3E00X28Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach
- 3E00X29Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
- 3E00X3ZIntroduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach
- 3E00X4ZIntroduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach
- 3E00XBZIntroduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach
- 3E00XGCIntroduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
- 3E00XGFIntroduction of Other Enzymatic/Chemical Agent into Skin and Mucous Membranes, External Approach
- 3E00XKZIntroduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
- 3E00XMZIntroduction of Pigment into Skin and Mucous Membranes, External Approach
- 3E00XNZIntroduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
- 3E00XTZIntroduction of Destructive Agent into Skin and Mucous Membranes, External Approach
- 3E0102AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach
- 3E01305Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
- 3E0130MIntroduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
- 3E01328Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
- 3E01329Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach
- 3E0132AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach